William Huhn, Pfizer, Inc. 
Timothy Jefferson, Office of General Counsel, HHS 
Dorothy Jessop, Department of Agriculture 
Judy Johnson, Congressional Research Service 
Mary Jane Johnson, Pall Corporation 
Attila Kadar, Food and Drug Administration 
Geoffrey Karny, Finnegan, Henderson, Farabcw, Garrett, & Dunne r 
Paul Kaufman, Pharmaceutical Manufacturer's Association 
John Kelley, Agrigenetics Corporation 
Rihito Kimura, Kennedy Institute 
Sheldon Krimsky, Tufts University 
Marc Kusnetz, NBC 
Max Marsh, Eli Lilly & Company 
Dan Meyer, Tracor Jitco, Inc. 
Bernard Mlynczak, Monsanto Company 
Bill Muth, Eli Lilly & Company 
DeLill Nasser, National Science Foundation 
Colin Norman, Science Magazine 
Jerry Norman, GB Fermentation Industries 
Tabitha Powledge, Biotechnology Magazine 
Jeremy Rifkin, Foundation on Economic Trends 
Torn Ryan, BioTechnica International, Inc. 
Mark Segal, Environmental Protection Agency 
Paul Shapiro 
Janet Shoemaker, American Society for Microbiology 
A1 Storey, NBC 
Jeff Trewhitt, McGraw Hill 
Joseph Van Houten, Schering-Plough Corporation 
Michael Vodkin, USAMRIID 
Lidia Watrud, Monsanto Company 
(Note: Page 4 is a blank page when the minutes 
are published in booklet form.) 
[i m 
